Long Non Coding RNAs (lncRNAs) Are Dysregulated in Malignant Pleural Mesothelioma (MPM)

Malignant Pleural Mesothelioma (MPM) is an aggressive cancer that is often diagnosed at an advanced stage and is characterized by a long latency period (20–40 years between initial exposure and diagnosis) and prior exposure to asbestos. Currently accurate diagnosis of MPM is difficult due to the lack of sensitive biomarkers and despite minor improvements in treatment, median survival rates do not exceed 12 months. Accumulating evidence suggests that aberrant expression of long non-coding RNAs (lncRNAs) play an important functional role in cancer biology. LncRNAs are a class of recently discovered non-protein coding RNAs >200 nucleotides in length with a role in regulating transcription. Here we used NCode long noncoding microarrays to identify differentially expressed lncRNAs potentially involved in MPM pathogenesis. High priority candidate lncRNAs were selected on the basis of statistical (P<0.05) and biological significance (>3-fold difference). Expression levels of 9 candidate lncRNAs were technically validated using RT-qPCR, and biologically validated in three independent test sets: (1) 57 archived MPM tissues obtained from extrapleural pneumonectomy patients, (2) 15 cryopreserved MPM and 3 benign pleura, and (3) an extended panel of 10 MPM cell lines. RT-qPCR analysis demonstrated consistent up-regulation of these lncRNAs in independent datasets. ROC curve analysis showed that two candidates were able to separate benign pleura and MPM with high sensitivity and specificity, and were associated with nodal metastases and survival following induction chemotherapy. These results suggest that lncRNAs have potential to serve as biomarkers in MPM.

[1]  Alfonso Baldi,et al.  Global Gene Expression Profiling Of Human Pleural Mesotheliomas: Identification of Matrix Metalloproteinase 14 (MMP-14) as Potential Tumour Target , 2009, PloS one.

[2]  J. Leigh,et al.  After Helsinki: a multidisciplinary review of the relationship between asbestos exposure and lung cancer, with emphasis on studies published during 1997-2004. , 2004, Pathology.

[3]  John N. Hutchinson,et al.  An architectural role for a nuclear noncoding RNA: NEAT1 RNA is essential for the structure of paraspeckles. , 2009, Molecular cell.

[4]  Pamela A. Silver,et al.  Nuclear transport and cancer: from mechanism to intervention , 2004, Nature Reviews Cancer.

[5]  Claude Denham,et al.  Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  S. Shappell.  Clinical utility of prostate carcinoma molecular diagnostic tests. , 2008, Reviews in urology.

[7]  J. Mattick,et al.  The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. , 2011, Cancer research.

[8]  C. Croce,et al.  microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer , 2011, Oncogene.

[9]  R. Drapkin,et al.  PAX8 Reliably Distinguishes Ovarian Serous Tumors From Malignant Mesothelioma , 2010, The American journal of surgical pathology.

[10]  K. Dahlman-Wright,et al.  Molecular characterization of tumour heterogeneity and malignant mesothelioma cell differentiation by gene profiling , 2005, The Journal of pathology.

[11]  E. Duhig,et al.  Phenotypes and Karyotypes of Human Malignant Mesothelioma Cell Lines , 2013, PloS one.

[12]  David J Sugarbaker,et al.  Tumorigenesis and Neoplastic Progression Identification of Novel Candidate Oncogenes and Tumor Suppressors in Malignant Pleural Mesothelioma Using Large-Scale Transcriptional Profiling , 2005 .

[13]  J. Pilewski,et al.  Successful adenovirus-mediated gene transfer in an in vivo model of human malignant mesothelioma. , 1994, The Annals of thoracic surgery.

[14]  W. Berger,et al.  Synergistic Anticancer Activity of Arsenic Trioxide with Erlotinib Is Based on Inhibition of EGFR-Mediated DNA Double-Strand Break Repair , 2013, Molecular Cancer Therapeutics.

[15]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[16]  Ming Liu,et al.  Long intergenic noncoding RNA HOTAIR is overexpressed and regulates PTEN methylation in laryngeal squamous cell carcinoma. , 2013, The American journal of pathology.

[17]  J. Leigh,et al.  Diagnosis of epithelial mesothelioma using tree‐based regression analysis and a minimal panel of antibodies , 2009, Pathology.

[18]  B. Blencowe,et al.  The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. , 2010, Molecular cell.

[19]  Michael Thomas,et al.  MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer , 2003, Oncogene.

[20]  P. Pandolfi,et al.  A coding-independent function of gene and pseudogene mRNAs regulates tumour biology , 2010, Nature.

[21]  Howard Y. Chang,et al.  Detection of Long Non-Coding RNA in Archival Tissue: Correlation with Polycomb Protein Expression in Primary and Metastatic Breast Carcinoma , 2012, PloS one.

[22]  Chuanliang Xu,et al.  The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor. , 2013, Urologic oncology.

[23]  K. Fong,et al.  Epigenomic targets for the treatment of respiratory disease. , 2009, Expert opinion on therapeutic targets.

[24]  R. Stupp,et al.  Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[25]  C. Proud,et al.  mTOR signaling regulates the processing of pre-rRNA in human cells , 2011, Nucleic acids research.

[26]  Paulo P. Amaral,et al.  Long noncoding RNAs in mouse embryonic stem cell pluripotency and differentiation. , 2008, Genome research.

[27]  S. Koschmieder,et al.  The Long Noncoding MALAT-1 RNA Indicates a Poor Prognosis in Non-small Cell Lung Cancer and Induces Migration and Tumor Growth , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[28]  B. Ghanim,et al.  Suppression of activin A signals inhibits growth of malignant pleural mesothelioma cells , 2012, British Journal of Cancer.

[29]  Philip J. Landrigan,et al.  Occupational Exposure to Asbestos and Ovarian Cancer: A Meta-analysis , 2011, Environmental health perspectives.

[30]  S. Knuutila,et al.  Gene expression profiling of malignant mesothelioma cell lines: cDNA array study , 2001, International journal of cancer.

[31]  Xuerui Yang,et al.  An Extensive MicroRNA-Mediated Network of RNA-RNA Interactions Regulates Established Oncogenic Pathways in Glioblastoma , 2011, Cell.

[32]  L. Mutti,et al.  In vitro and in vivo characterization of highly purified Human Mesothelioma derived cells , 2010, BMC Cancer.

[33]  S. Miyano,et al.  Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. , 2011, Cancer research.

[34]  K. Zatloukal,et al.  Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. , 2007, Gastroenterology.

[35]  C. Gong,et al.  Long non‐coding RNA HOTAIR is an independent prognostic marker for nasopharyngeal carcinoma progression and survival , 2013, Cancer science.

[36]  Howard Y. Chang,et al.  Long noncoding RNA HOTAIR reprograms chromatin state to promote cancer metastasis , 2010, Nature.

[37]  Sin Lam Tan,et al.  Complex Loci in Human and Mouse Genomes , 2006, PLoS genetics.

[38]  Marius Žemaitis,et al.  Promoter methylation of RASSF1A, RARbeta and DAPK predict poor prognosis of patients with malignant mesothelioma. , 2006, Lung cancer.

[39]  G. Gordon,et al.  Transcriptional profiling of mesothelioma using microarrays. , 2005, Lung cancer.

[40]  T. Kwok,et al.  Induction of drug resistance and transformation in human cancer cells by the noncoding RNA CUDR. , 2007, RNA.

[41]  D. Henderson,et al.  Validation of tissue microarray technology in malignant pleural mesothelioma , 2011, Pathology.

[42]  Randeep Rakwal,et al.  MALAT‐1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility‐related genes , 2010, FEBS letters.

[43]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[44]  Howard Y. Chang,et al.  Molecular mechanisms of long noncoding RNAs. , 2011, Molecular cell.

[45]  P. Pandolfi,et al.  A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language? , 2011, Cell.

[46]  Haiyang Xie,et al.  Overexpression of Long Non-coding RNA HOTAIR Predicts Tumor Recurrence in Hepatocellular Carcinoma Patients Following Liver Transplantation , 2011, Annals of Surgical Oncology.

[47]  M. Nishizawa,et al.  Stabilization of human interferon-α1 mRNA by its antisense RNA , 2012, Cellular and Molecular Life Sciences.

[48]  Yingdong Zhao,et al.  Analysis of Gene Expression Data Using BRB-Array Tools , 2007, Cancer informatics.

[49]  H. Hricak,et al.  Thoracic metastasis in advanced ovarian cancer: comparison between computed tomography and video-assisted thoracic surgery , 2011, Journal of gynecologic oncology.

[50]  G. Carmichael,et al.  Altered nuclear retention of mRNAs containing inverted repeats in human embryonic stem cells: functional role of a nuclear noncoding RNA. , 2009, Molecular cell.

[51]  G. Heinze,et al.  Immunoexpression of PAX 8 in Endometrial Cancer: Relation to High-Grade Carcinoma and p53 , 2011, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.